Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 113 | 406 | 496 | 712 | 751 |
| Cost of Goods | 0 | 14,085 | 0 | 0 | 0 |
| Gross Profit | 0 | -13,956 | 381 | 525 | 505 |
| Operating Expenses | 5,897 | -9,092 | 5,530 | 3,612 | 4,062 |
| Operating Income | -5,784 | -4,502 | -5,034 | -2,900 | -3,311 |
| Interest Expense | 15 | 35 | 12 | 24 | 17 |
| Other Income | 0 | -188 | 0 | 0 | 16 |
| Pre-tax Income | -5,800 | -4,726 | -5,046 | -2,924 | -3,311 |
| Net Income Continuous | -5,800 | -4,538 | -5,046 | -2,924 | -3,311 |
| Net Income Discontinuous | 0 | -1,998,000 | 0 | 0 | 0 |
| Net Income | $-5,800 | $-4,538 | $-5,046 | $-2,924 | $-3,311 |
| EPS Basic Total Ops | -9.50 | -8.00 | -9.50 | -5.50 | -6.00 |
| EPS Basic Continuous Ops | -58,000.00 | -45,380.00 | -50,460.00 | -29,240.00 | -33,110.00 |
| EPS Basic Discontinuous Ops | N/A | -19,980,000.00 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -9.50 | -8.00 | -9.50 | -5.50 | -6.00 |
| EPS Diluted Continuous Ops | -58,000.00 | -45,380.00 | -50,460.00 | -29,240.00 | -33,110.00 |
| EPS Diluted Discontinuous Ops | N/A | -19,980,000.00 | N/A | N/A | N/A |
| EBITDA(a) | $-5,784 | $-4,502 | $-5,034 | $-2,900 | $-3,311 |